Sidley Advises KKR on Its Investment in Nordic Bioscience

Sidley advised KKR on its investment in Nordic Bioscience, a Danish biomarker development company.

The Sidley team was led by Till Lefranc with support from Jakob Egle and Arjun Sehgal (M&A), and included Peter S. Choi, Jeffrey P. Kushan, and Timothy Q. Li (IP Litigation); Helen Middleton (Food, Drug and Medical Device Regulatory); Patrick Harrison, Rosanna Connolly, and Mia Gal (Antitrust/Competition); Oliver Currall and Laurence Wilcock (Tax); and Sven De Knop and Alessandra Moroni (Global Arbitration, Trade and Advocacy).